ADPT Adaptive Biotechnologies Corp Year-over-year net earnings per share growth for the last 12 months
The quarterly EPS trajectory clearly demonstrates Adaptive Biotechnologies (ADPT) strategy of leadership in genomic profiling and the implementation of clonoSEQ. The business model's efficiency is based on cloud computing for data analysis, while proprietary sequencing ensures high market value for services. Meanwhile, -72.90 shapes the current metric, allowing for a real-time assessment of per-share profit dynamics against the backdrop of US monetary policy.
ADPT (Adaptive Biotechnologies Inc.): analytical breakdowns and indicator data
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Capital Adaptive Biotechnologies|ADPT - Long-Term Debt to Capital|Short-Term Debt to Capital Adaptive Biotechnologies|ADPT - Company Aggregate Debt|Debts to Book Capitalization Adaptive Biotechnologies Corp|ADPT - Company Long-Term Debts|Company Short-Term Debt Adaptive Biotechnologies|Quick Liquidity Indicator adaptivebiotech.com
- earnings and market multiples details:
ADPT - Profit After Payment of Taxes|Projected Future Earnings Adaptive Biotechnologies|ADPT - Business Payback Period|Projected Price to Earnings Adaptive Biotechnologies Corp|ADPT - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Adaptive Biotechnologies Corp|ADPT - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Adaptive Biotechnologies|ADPT - Earnings per share for the trailing year|Quarterly EPS earnings growth adaptivebiotech.com|ADPT - Earnings per share growth in current year|Earnings growth forecast for next year Adaptive Biotechnologies
Summary company analysis:Adaptive Biotechnologies Corporation - ADPT
Adaptive Biotechnologies is scaling the commercialization of immunosequencing through strategic contracts with pharmaceutical behemoths. This indicator measures the rate of change in quarterly earnings per share. By analyzing the level of quarterly EPS dynamics, an investor assesses the efficiency of cost management relative to revenue. A positive trend confirms the company's ability to monetize R&D solutions without a loss in demand. This serves as fundamental confirmation of capital protection against inflationary risks.
Competitor analysis
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Celldex - Quarterly EPS earnings growth|AUPH - Quarterly EPS earnings growth|BCRX: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months VERA|DNTH (Dianthus Therapeutics, Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Pharvaris NV|Year-over-year earnings per share growth for the last twelve months AbCellera Corp (ABCL)|TRML: Year-over-year net earnings per share trend for the last twelve months|Precigen, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months PHAR (pharming.com)|Nektar Therapeutics Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Upstream Bio, Inc. UPB|ZBIO (Zenas Biopharma, Inc.) - Year-over-year net earnings per share growth for the last 12 months|IMNM (Immunome Bio) - Year-over-year earnings per share growth for the last twelve months|GOSS (Gossamer Bio, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months kalvista.com KALV|Year-over-year net earnings per share growth for the last 12 months SEPN (Septerna)|PVLA (Pieris Pharma) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth SVRA (Savara Corp)|Rigel Corp - Year-over-year earnings per share growth for the last twelve months|AnaptysBio, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months astriatx.com ATXS|enGene (ENGN) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months rapt.com (RAPT)|Year-over-year net earnings per share growth for the last 12 months JBIO|ACRS (Aclaris Therapeutics, Inc) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth KYTX|TLSA - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth CABA (Cabaletta Bio)|VTYX - Year-over-year net earnings per share growth for the last 12 months|Theratechnologies Inc - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months AVTX (Avalo Therapeutics Inc)|Eledon Pharmaceuticals (ELDN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months AGEN|Year-over-year earnings per share growth for the last twelve months Climb Bio|Earnings per share growth in annualized terms for the last twelve months zurabio.com ZURA|Year-over-year earnings per share growth for the last twelve months aTyr (ATYR)|Year-over-year earnings per share growth for the last twelve months ADAG (adagene.com)|Year-over-year earnings per share growth for the last twelve months Ikena Oncology IMA|Shattuck Labs Inc (STTK) - Earnings per share growth in annualized terms for the last twelve months|Equillium Bio - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Connect Biopharma (CNTB)|IMUX: Quarterly EPS earnings growth|ATRA - Year-over-year net earnings per share change for the last twelve months|IFRX (InflaRx NV) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months x4pharma.com XFOR|Year-over-year earnings per share growth for the last twelve months Adicet Bio (ACET)|Year-over-year net earnings per share change for the last twelve months celularity.com|Quarterly EPS earnings growth INMB (INmune Bio Corp)|Quarterly EPS earnings growth Barinthus Biotherapeutics Corp BRNS|Kezar Life Sciences - Quarterly EPS earnings growth|SABS (sabbiotherapeutics.com) - Year-over-year earnings per share growth for the last 12 months|Akari Therapeutics Plc (AKTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months ENLV (Enlivex Therapeutics Ltd.)|Year-over-year net earnings per share growth for the last 12 months QTTB|GOVX (GeoVax Corp) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Edesa Biotech, Inc. (EDSA)|IBIO: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth CARM (Carisma Therapeutics Inc.)|Year-over-year earnings per one share growth for the last 12 months XTLB|Bolt Bio - Quarterly EPS earnings growth|HCWB - Quarterly EPS earnings growth|aptevotherapeutics.com (APVO) - Year-over-year earnings per share growth for the last twelve months|aimimmuno.com - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Aditxt Inc.|Year-over-year net earnings per share growth for the last 12 months GRI Bio Inc (GRI)|Quarterly EPS earnings growth XRTX|Quarterly EPS earnings growth Vyome Therapeutics (HIND)|Revelation Biosciences - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months INDP|Scinai Immunotherapeutics Ltd. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months CalciMedica, Inc. CALI|affimed.com (AFMD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Allakos|Year-over-year earnings per share growth for the last twelve months HOOKIPA Pharma, Inc.|Year-over-year net earnings per share growth for the last 12 months IGM Bio (IGMS)|Year-over-year net earnings per share growth for the last 12 months ITOS (iTeos Therapeutics, Inc.)|Quarterly EPS earnings growth Ocean Biomedical Inc (OCEA)|Year-over-year earnings per share growth for the last twelve months TC BioPharm (Holdings) PLC TCBP|THRD: Year-over-year earnings per share growth for the last 12 months
